🔗 Permalink

Inventor profile of:

James E. Bradner

City:

Weston, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2025-01-30

Top Assignees for applications by James E. Bradner

The entities that hold a legal rights for patent applications filed by inventor Bradner James E.:

Dana-Farber-Cancer Institute, Inc. 39 Boston, MA United States
President and Fellows of Harvard College 5 Cambridge, MA United States
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. 2 Boston, MA United States
Colorado State University Research Foundation 2 Fort Collins, CO United States
UNIVERSITY OF NOTRE DAME DU LAC 2 South Bend, IN United States
THE BROAD INSTITUTE, INC. 1 Cambridge, MA United States
Case Western Reserve University 1 Cleveland, OH United States
TRUSTEES OF BOSTON UNIVERSITY 1 Boston, MA United States
WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH 1 Cambridge, MA United States
Regents of the University of Minnesota 1 Minneapolis, MN United States
Dana-Farber Cance Institute, Inc. 1 Boston, MA United States
The General Hospital Corporation 1 Boston, MA United States
NOVARTIS AG 1 Basel, Switzerland
The General Hospital Corporation d/b/a Massachusetts General Hospital 1 Boston, MA United States
UNIVERSITY OF MASSACHUSETTS 1 Boston, MA United States

Recent patent applications by Bradner James E.

James E. Bradner from Weston, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-01-30

US20250034126A1

Chemistry; metallurgy

CHROMOBOX PROTEIN INHIBITORS AND USES THEREOF

#2 | 2024-11-21

US20240384007A1

Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION

#3 | 2024-05-02

US20240140999A1

Chemistry; metallurgy

STABILIZED PEPTIDE-MEDIATED TARGETED PROTEIN DEGRADATION

#4 | 2022-04-21

US20220119416A9

Chemistry; metallurgy

BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF

#5 | 2021-12-23

US20210393647A9

Human necessities

ACETAMIDE THIENOTRIAZOLODIAZEPINES AND USES THEREOF

#6 | 2021-07-22

US20210221826A1

Chemistry; metallurgy

BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF

#7 | 2021-07-08

US20210206779A9

Chemistry; metallurgy

CYANO THIENOTRIAZOLODIAZEPINES AND USES THEREOF

#8 | 2021-04-08

US20210100813A1

Human necessities

COMBINATION THERAPY FOR CANCER USING BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITORS

#9 | 2021-04-01

US20210093644A1

Human necessities

Acetamide thienotriazolodiazepines and uses thereof

#10 | 2020-11-26

US20200368248A1

Human necessities

Mechanism of resistance to bet bromodomain inhibitors

#11 | 2020-11-12

US20200354413A1

Chemistry; metallurgy

STABILIZED PEPTIDE-MEDIATED TARGETED PROTEIN DEGRADATION

#12 | 2020-10-29

US20200339704A1

Chemistry; metallurgy

Compositions and methods for selective protein degradation

#13 | 2020-06-25

US20200199150A1

Chemistry; metallurgy

Cyano thienotriazolodiazepines and uses thereof

#14 | 2020-06-04

US20200172553A9

Chemistry; metallurgy

BIVALENT BROMODOMAIN INHIBITORS AND USES THEREOF

#15 | 2020-02-06

US20200039968A9

Chemistry; metallurgy

EZH2 inhibitors and uses thereof

#16 | 2019-06-27

US20190192532A1

Human necessities

COMBINATION THERAPY OF BROMODOMAIN INHIBITORS AND CHECKPOINT BLOCKADE

#17 | 2019-05-09

US20190135796A1

Chemistry; metallurgy

EZH2 INHIBITORS AND USES THEREOF

#18 | 2019-05-09

US20190135790A1

Chemistry; metallurgy

Diaminopyrimidine benzenesulfone derivatives and uses thereof

#19 | 2019-02-14

US20190046541A1

Human necessities

Acetamide thienotriazolodiazepines and uses thereof

#20 | 2019-01-08

US15401902

Human necessities

Treatment of protein degradation disorders

#21 | 2019-01-03

US20190000860A1

Human necessities

USE OF COMPOSITIONS MODULATING CHROMATIN STRUCTURE FOR GRAFT VERSUS HOST DISEASE (GVHD)

#22 | 2018-12-13

US20180354973A1

Chemistry; metallurgy

Bivalent bromodomain inhibitors and uses thereof

#23 | 2018-10-18

US20180297993A1

Chemistry; metallurgy

EZH2 inhibitors and uses thereof

#24 | 2018-03-01

US20180057510A1

Chemistry; metallurgy

Synthesis and utility of new capgroup largazole analogs

#25 | 2018-02-15

US20180044376A1

Chemistry; metallurgy

Method for preparing largazole analogs and uses thereof

#26 | 2017-10-12

US20170292959A1

Physics

PLASMIDS COMPRISING INTERNAL RIBOSOMAL ENTRY SITES AND USES THEREOF

#27 | 2017-09-21

US20170267630A1

Chemistry; metallurgy

Class-and isoform-specific HDAC inhibitors and uses thereof

#28 | 2017-05-25

US20170145023A1

Chemistry; metallurgy

Diazepane derivatives and uses thereof

#29 | 2017-05-25

US20170145013A1

Chemistry; metallurgy

Dihydropteridinone derivatives and uses thereof

#30 | 2017-01-12

US20170008895A1

Chemistry; metallurgy

Uses of diazepane derivatives

#31 | 2016-12-01

US20160347750A1

Chemistry; metallurgy

DIHYDROPTERIDINONE DERIVATIVES AND USES THEREOF

#32 | 2016-12-01

US20160347749A1

Chemistry; metallurgy

Diazepane derivatives and uses thereof

#33 | 2016-11-17

US20160332993A1

Chemistry; metallurgy

Diaminopyrimidine benzenesulfone derivatives and uses thereof

#34 | 2016-09-29

US20160279141A1

Human necessities

Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors

#35 | 2016-06-16

US20160168154A1

Chemistry; metallurgy

Inhibitors of transcription factors and uses thereof

#36 | 2016-05-26

US20160146817A1

Physics

DOT1L probes

#37 | 2016-04-07

US20160095867A1

Human necessities

BET INHIBITION THERAPY FOR HEART DISEASE

#38 | 2016-03-03

US20160060269A1

Chemistry; metallurgy

DOT1L inhibitors

#39 | 2016-02-25

US20160051619A1

Human necessities

Treatment of protein degradation disorders

#40 | 2016-02-04

US20160033519A1

Physics

Bromodomain binding reagents and uses thereof

#41 | 2015-12-10

US20150352079A1

Human necessities

Selective histone deacetylase 8 inhibitors

#42 | 2015-10-29

US20150307444A1

Chemistry; metallurgy

Class- and isoform-specific HDAC inhibitors and uses thereof

#43 | 2015-10-15

US20150291521A1

Chemistry; metallurgy

Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors

#44 | 2015-07-16

US20150197497A1

Chemistry; metallurgy

SELECTIVE INHIBITORS OF HISTONE DEACETYLASE ISOFORM 6 AND METHODS THEREOF

#45 | 2015-06-25

US20150174138A1

Human necessities

Diagnostic and treatment methods in subjects having or at risk of developing resistance to cancer therapy

#46 | 2015-06-18

US20150167062A1

Chemistry; metallurgy

Genome-wide Method of Assessing Interactions Between Chemical Entities And Their Target Molecules

#47 | 2006-10-26

US20060239909A1

Human necessities

Treatment of protein degradation disorders

InventorID:

1195774 ⎘